Veradigm EPS - Earnings per Share 2010-2022 | MDRX
Veradigm eps - earnings per share from 2010 to 2022. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Veradigm Annual EPS | |
|---|---|
| 2022 | $-0.77 |
| 2021 | $1.01 |
| 2020 | $4.37 |
| 2019 | $-1.10 |
| 2018 | $2.07 |
| 2017 | $-1.09 |
| 2016 | $-0.14 |
| 2015 | $-0.01 |
| 2014 | $-0.37 |
| 2013 | $-0.59 |
| 2012 | $-0.01 |
| 2011 | $0.39 |
| 2010 | $-0.03 |
| 2010 | $0.42 |
| 2009 | $0.21 |
| Veradigm Quarterly EPS | |
|---|---|
| 2022-12-31 | $-0.52 |
| 2022-09-30 | $0.12 |
| 2022-06-30 | $-0.54 |
| 2022-03-31 | $0.17 |
| 2021-12-31 | $0.68 |
| 2021-09-30 | $0.12 |
| 2021-06-30 | $0.15 |
| 2021-03-31 | $0.06 |
| 2020-12-31 | $4.55 |
| 2020-09-30 | $0.00 |
| 2020-06-30 | $-0.05 |
| 2020-03-31 | $-0.13 |
| 2019-12-31 | $-0.13 |
| 2019-09-30 | $-0.03 |
| 2019-06-30 | $-0.90 |
| 2019-03-31 | $-0.04 |
| 2018-12-31 | $2.13 |
| 2018-09-30 | $-0.20 |
| 2018-06-30 | $0.36 |
| 2018-03-31 | $-0.22 |
| 2017-12-31 | $0.03 |
| 2017-09-30 | $-0.16 |
| 2017-06-30 | $-0.85 |
| 2017-03-31 | $-0.11 |
| 2016-12-31 | $-0.04 |
| 2016-09-30 | $-0.06 |
| 2016-06-30 | $-0.05 |
| 2016-03-31 | $0.01 |
| 2015-12-31 | $0.09 |
| 2015-09-30 | $-0.03 |
| 2015-06-30 | $-0.01 |
| 2015-03-31 | $-0.06 |
| 2014-12-31 | $-0.01 |
| 2014-09-30 | $-0.15 |
| 2014-06-30 | $-0.09 |
| 2014-03-31 | $-0.12 |
| 2013-12-31 | $-0.12 |
| 2013-09-30 | $-0.27 |
| 2013-06-30 | $-0.13 |
| 2013-03-31 | $-0.07 |
| 2012-12-31 | $-0.13 |
| 2012-09-30 | $0.05 |
| 2012-06-30 | $0.04 |
| 2012-03-31 | $0.03 |
| 2011-12-31 | $0.14 |
| 2011-09-30 | $0.10 |
| 2011-06-30 | $0.08 |
| 2011-03-31 | $0.07 |
| 2010-12-31 | $-0.03 |
| 2010-09-30 | $0.01 |
| 2010-06-30 | $0.09 |
| 2010-05-31 | $0.00 |
| 2010-03-31 | $0.12 |
| 2010-02-28 | $0.12 |
| 2009-12-31 | $0.00 |
| 2009-11-30 | $0.10 |
| 2009-09-30 | $0.09 |
| 2009-08-31 | $0.09 |
| 2009-05-31 | $0.00 |
| 2009-02-28 | $0.09 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.487B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.769B | 58.23 |
| Hims & Hers Health (HIMS) | United States | $14.374B | 149.35 |
| Tempus AI (TEM) | United States | $11.826B | 0.00 |
| Doximity (DOCS) | United States | $10.774B | 49.88 |
| IRhythm Technologies (IRTC) | United States | $4.653B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.861B | 60.33 |
| Hinge Health (HNGE) | United States | $3.282B | 0.00 |
| Privia Health (PRVA) | United States | $2.664B | 182.08 |
| Enovis (ENOV) | United States | $1.720B | 9.59 |
| Phreesia (PHR) | United States | $1.560B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.537B | 0.00 |
| Schrodinger (SDGR) | United States | $1.501B | 0.00 |
| Azenta (AZTA) | United States | $1.357B | 63.06 |
| 10x Genomics (TXG) | United States | $1.331B | 0.00 |
| Omnicell (OMCL) | United States | $1.313B | 23.17 |
| Evolent Health (EVH) | United States | $1.086B | 92.50 |
| Claritev (CTEV) | United States | $0.657B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.595B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.514B | 0.00 |
| Talkspace (TALK) | United States | $0.448B | 134.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| TruBridge (TBRG) | United States | $0.337B | 746.67 |
| Outset Medical (OM) | United States | $0.336B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.263B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.251B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.156B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.138B | 0.00 |
| CareCloud (CCLD) | United States | $0.106B | 4.03 |
| Pulmonx (LUNG) | United States | $0.105B | 0.00 |
| American Well (AMWL) | United States | $0.105B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.094B | 0.00 |
| 111 (YI) | China | $0.069B | 0.00 |
| HeartBeam (BEAT) | United States | $0.051B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.046B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| Zhongchao (ZCMD) | China | $0.037B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.012B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |